Literature DB >> 33708556

Risk factors for perforated marginal ulcers following pancreaticoduodenectomy and prospective analysis of marginal ulcer development.

Andreas Minh Luu1, Sina Rabea Vogel1, Chris Braumann1, Michael Praktiknjo2, Philipp Höhn1, Sarah Förster3, Monika Janot1, Waldemar Uhl1, Orlin Belyaev1.   

Abstract

BACKGROUND: Perforated marginal ulcers (PMUs) are a feared long-term complication following pancreaticoduodenectomy (PD), which always require relaparotomy compared to marginal ulcers.
METHODS: First, we performed a retrospective chart review for all patients who underwent PD from 2007-2016 to identify incidence and risk factors associated with PMUs. Second, we analyzed follow up gastroscopies in all patients undergoing PD from 2007-2011 to identify the overall incidence of marginal ulcers.
RESULTS: A total of 725 patients underwent PD in the retrospective study period. 17 patients (2.3%) suffered from PMU at a median postoperative time of 13 months. These patients were significantly younger (median age: 49 vs. 62 years; P=0.02) and suffered most often from chronic pancreatitis (P<0.001). Smoking and alcohol consumption were significantly more common (P=0.01 and P=0.023). An elevated level of carcinoembryonic antigen and chronic pancreatitis were identified as independent risk factors. Overall, 373 patients were enrolled for prospective analysis. Marginal ulcers occurred in 5-5.9% over a postoperative period of 5 years.
CONCLUSIONS: Continuous treatment with proton-pump inhibitors for at least 5 years, immediate smoking cessation and follow-up gastroscopies are obligate for patients undergoing PD to avoid marginal ulcers and PMUs. 2021 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Pancreaticoduodenectomy (PD); marginal ulcer; pancreas; perforated marginal ulcer (PMU); pylorus preserving Whipple’s procedure

Year:  2021        PMID: 33708556      PMCID: PMC7944069          DOI: 10.21037/gs-20-763

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  27 in total

Review 1.  Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies.

Authors:  Valerie Wu Chao Ying; Song Hon H Kim; Khurram J Khan; Forough Farrokhyar; Joanne D'Souza; Scott Gmora; Mehran Anvari; Dennis Hong
Journal:  Surg Endosc       Date:  2014-08-27       Impact factor: 4.584

Review 2.  Proton pump inhibitors: an update of their clinical use and pharmacokinetics.

Authors:  Shaojun Shi; Ulrich Klotz
Journal:  Eur J Clin Pharmacol       Date:  2008-08-05       Impact factor: 2.953

3.  Post-pancreaticoduodenectomy hemorrhage. Incidence, diagnosis, and treatment.

Authors:  M J Mañas-Gómez; R Rodríguez-Revuelto; J Balsells-Valls; J J Olsina-Kissler; M Caralt-Barba; M Pérez-Lafuente; R Charco-Torra
Journal:  World J Surg       Date:  2011-11       Impact factor: 3.352

4.  Pylorus-preserving pancreatectomy: functional results.

Authors:  D R Hunt; R McLean
Journal:  Br J Surg       Date:  1989-02       Impact factor: 6.939

5.  Modified Single-Loop Reconstruction for Pancreaticoduodenectomy.

Authors:  Andreas M Luu; Ilgar Aghalarov; Chris Braumann; Waldemar Uhl; Orlin Belyaev
Journal:  J Vis Exp       Date:  2019-09-28       Impact factor: 1.355

6.  Preservation of the pylorus in pancreaticoduodenectomy.

Authors:  L W Traverso; W P Longmire
Journal:  Surg Gynecol Obstet       Date:  1978-06

Review 7.  Pylorus preserving pancreatoduodenectomy: an overview.

Authors:  P A Grace; H A Pitt; W P Longmire
Journal:  Br J Surg       Date:  1990-09       Impact factor: 6.939

8.  Pancreaticoduodenectomy. Surgical grand rounds--University of Michigan.

Authors:  C G Child; C F Frey
Journal:  Surg Clin North Am       Date:  1966-10       Impact factor: 2.741

9.  The advantages of pylorus-preserving pancreatoduodenectomy in malignant disease of the pancreas and periampullary region.

Authors:  J H Klinkenbijl; G P van der Schelling; W C Hop; R van Pel; H A Bruining; J Jeekel
Journal:  Ann Surg       Date:  1992-08       Impact factor: 12.969

Review 10.  The risks of long-term use of proton pump inhibitors: a critical review.

Authors:  Megan Jaynes; Avinash B Kumar
Journal:  Ther Adv Drug Saf       Date:  2018-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.